Absolutely. They should have access to this. These children, as you said earlier, the diseases are terminal. It's terrible. But again, I do want to get the other. The companies themselves are concerned about having adverse results [from compassionate use]. Absolutely. In a non clinical trial or whatever affect the ability to. And we all ought to be concerned about that because if there is a drug that could be helpful and it gets basically kiboshed because of one of these. (14:08–14:15)
CLAIM
Asserts that companies are worried about adverse results affecting drug approval.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
